These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12573194)

  • 1. C-reactive protein: the pawn has been promoted to queen.
    Yeh ET; Palusinski RP
    Curr Atheroscler Rep; 2003 Mar; 5(2):101-5. PubMed ID: 12573194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy.
    Yu H; Rifai N
    Clin Biochem; 2000 Nov; 33(8):601-10. PubMed ID: 11166006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members.
    Di Napoli M; Schwaninger M; Cappelli R; Ceccarelli E; Di Gianfilippo G; Donati C; Emsley HC; Forconi S; Hopkins SJ; Masotti L; Muir KW; Paciucci A; Papa F; Roncacci S; Sander D; Sander K; Smith CJ; Stefanini A; Weber D
    Stroke; 2005 Jun; 36(6):1316-29. PubMed ID: 15879341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New frontiers for cardiac risk assessment: C-reactive protein.
    Martin CM; Almond J
    Consult Pharm; 2006 Mar; 21(3):188-91, 195-6, 205-6. PubMed ID: 16573367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
    Guijarro C
    Circulation; 2001 Nov; 104(22):E127. PubMed ID: 11723039
    [No Abstract]   [Full Text] [Related]  

  • 7. The antiinflammatory effects of statins.
    McCullough PA
    N Engl J Med; 2001 Oct; 345(16):1209; author reply 1210-1. PubMed ID: 11642241
    [No Abstract]   [Full Text] [Related]  

  • 8. High sensitivity C-reactive protein in cardiovascular risk assessment. CRP mania or useful screening?
    Sellmayer A; Limmert T; Hoffmann U
    Int Angiol; 2003 Mar; 22(1):15-23. PubMed ID: 12771851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of C-reactive protein in atherogenesis].
    Boncler M; Luzak B; Watala C
    Postepy Hig Med Dosw (Online); 2006; 60():538-46. PubMed ID: 17060895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aspirin (325 mg/day) on serum high-sensitivity C-reactive protein, cytokines, and adhesion molecules in healthy volunteers.
    Azar RR; Klayme S; Germanos M; Kassab R; Tawm S; Aboujaoudé S; Naman R
    Am J Cardiol; 2003 Jul; 92(2):236-9. PubMed ID: 12860235
    [No Abstract]   [Full Text] [Related]  

  • 12. C-reactive protein (CRP)-lowering agents.
    Prasad K
    Cardiovasc Drug Rev; 2006; 24(1):33-50. PubMed ID: 16939632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein, antiinflammatory drugs, and quality of life in diabetes.
    Cummings DM; King DE; Mainous AG
    Ann Pharmacother; 2003 Nov; 37(11):1593-7. PubMed ID: 14565804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease.
    Bickel C; Rupprecht HJ; Blankenberg S; Espiniola-Klein C; Schlitt A; Rippin G; Hafner G; Treude R; Othman H; Hofmann KP; Meyer J;
    Am J Cardiol; 2002 Apr; 89(8):901-8. PubMed ID: 11950425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein is an essential aspect of cardiovascular risk factor stratification.
    Yeh ET
    Can J Cardiol; 2004 Aug; 20 Suppl B():93B-96B. PubMed ID: 15309212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of high-sensitivity CRP concentration with the extent of coronary atherosclerosis in men with symptoms of ischemic heart disease].
    Piechota W; Piechota W
    Pol Merkur Lekarski; 2005 May; 18(107):511-5. PubMed ID: 16161944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease.
    Nidorf M; Thompson PL
    Am J Cardiol; 2007 Mar; 99(6):805-7. PubMed ID: 17350370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
    Ridker PM; Cushman M; Stampfer MJ; Tracy RP; Hennekens CH
    N Engl J Med; 1997 Apr; 336(14):973-9. PubMed ID: 9077376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
    Koenig W
    Int J Cardiol; 2005 Feb; 98(2):199-206. PubMed ID: 15686768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery calcium scanning should be used for primary prevention: pros and cons.
    Nasir K; Shaw LJ; Budoff MJ; Ridker PM; Peña JM
    JACC Cardiovasc Imaging; 2012 Jan; 5(1):111-8. PubMed ID: 22239900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.